0001437749-23-012180.txt : 20230502 0001437749-23-012180.hdr.sgml : 20230502 20230502214536 ACCESSION NUMBER: 0001437749-23-012180 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230429 FILED AS OF DATE: 20230502 DATE AS OF CHANGE: 20230502 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Danahy Kevin Patrick CENTRAL INDEX KEY: 0001913245 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37744 FILM NUMBER: 23881437 MAIL ADDRESS: STREET 1: 50 TEABERRY LANE CITY: BRAINTREE STATE: MA ZIP: 02184 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Pulse Biosciences, Inc. CENTRAL INDEX KEY: 0001625101 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 465696597 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3957 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 510-906-4600 MAIL ADDRESS: STREET 1: 3957 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 FORMER COMPANY: FORMER CONFORMED NAME: Electroblate, Inc. DATE OF NAME CHANGE: 20141113 4 1 rdgdoc.xml FORM 4 X0407 4 2023-04-29 0001625101 Pulse Biosciences, Inc. PLSE 0001913245 Danahy Kevin Patrick C/O PULSE BIOSCIENCES, INC. 3957 POINT EDEN WAY HAYWARD CA 94545 1 Chief Executive Officer 0 Stock Option (right to buy) 6.44 2023-04-29 4 A 0 500000 A 2033-04-29 Common Stock 500000 500000 D The option was granted on April 29, 2023 under the Issuer's 2017 Equity Incentive Plan. The shares subject to the option are subject to four tranches of performance-based vesting criteria tied to Issuer's market capitalization, with no vesting until the Issuer's market capitalization exceeds $1 billion, in all cases, subject to the Reporting Person's continued service through each vesting milestone. Not applicable. /s/ Kenneth B. Stratton, as Attorney-in-Fact 2023-05-02